معرفی
Håvard Attramadal holds the position of Professor and Head of Department at the Department of Surgical Research, University of Oslo. He leads the Molecular Cardiology Research Group within the Institute of Surgical Research. His primary affiliation is with the National Hospital in Oslo.
Research Focus: Dr. Attramadal’s work centers on molecular mechanisms underlying cardiovascular diseases, particularly heart failure, myocardial infarction, and cardiac remodeling. Key areas include CCN protein regulation, inflammatory pathways in cardiac injury, and therapeutic interventions targeting extracellular matrix dynamics. His studies often utilize mouse models and in vitro systems to explore signaling pathways and gene therapy applications.
Publications Overview: Over 50 peer-reviewed articles since 2001 reflect contributions to understanding cardioprotective mechanisms, mitochondrial dysfunction in heart failure, and the role of matricellular proteins in fibrosis. Recent work emphasizes SLAMF1-derived peptides, NAD+ metabolism, and NLRP3 inflammasome modulation in cardiac protection.
Awards/Grants: No specific awards listed, but sustained research activity suggests institutional or competitive grant support for his lab’s projects.
Labs/Teams: Directly oversees the Molecular Cardiology Research Group, collaborating with multidisciplinary teams on translational cardiovascular research.
